JAMES JOHNSON
Profile
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
EXECUTIVE OFFICER, DIRECTOR
EXECUTIVE OFFICER
EXECUTIVE OFFICER
MARY TEDD ALLEN, JOSEPH BEECHEM, JOSEPH M. BEECHEM, WAYNE BURNS, J. WAYNE COWENS, JOHN WAYNE COWENS, H. PERRY FELL, PERRY FELL, JENNIFER FONSTAD, JENNIFER SCOTT FONSTAD, NICHOLAS GALAKATOS, NICHOLAS GALAKTOS, ROBERT BRADLEY GRAY, FINNY KURUVILLA, NALINI MURDTER, GREGORY NORDEN, GARY RIORDAN, BARNEY SAUNDERS, BRUCE SEELEY, BRUCE J. SEELEY, KATHRYN SURACE-SMITH, CHARLES WAITE, WILLIAM D. YOUNG, WILLIAMS D YOUNG
DIRECTOR
EXECUTIVE OFFICER
DIRECTOR
DAN BRADBURY, DANIEL BRADBURY, LUIS CALMELL DEL SOLAR, LUIS CALMELL DEL SOLAR DIAZ, RONALD GOURLEY, HAL HORNBERG, HAL HORNBURG, DANIEL HOSLER, JAMES HOSLER, RAFAEL JAQUE, DALE JURCISIN, THOMAS MCGINN, CHRISTOPHER MILLER, MICHAEL O-SHEA, PATRICK OHLIN, BRUCE STEWART, DAVID MCCANN SWEENEY, RICHARD WALLACE
EXECUTIVE OFFICER
EXECUTIVE OFFICER
DIRECTOR
JERRY BAACK, JERRY J. BAACK, BLAKE BONJEAN, LISA BREZONIK, LISA M. BREZONIK, JOE CHYBOWSKI, JOSEPH CHYBOWSKI, JOSEPH M. CHYBOWSKI, MARY JANE CROCKER, MARY JAYNE CROCKER, MARK M. DWYER, MARK E. HOKANSON, JAMES S. JOHNSON, DAVID JURAN, DAVID B. JURAN, MOHAMMED LAWAL, STEVEN M. MINN, DOUGLAS PARISH, DOUGLAS J. PARISH, RACHAEL M. PETERSEN, NICK PLACE, NICK L. PLACE, DANIEL POPPE, LISA SALAZAR, LISA M. SALAZAR, JEFF SHELLBERG, JEFFREY D. SHELLBERG, THOMAS P. TRUTNA, THOMAS PAUL TRUTNA, TOM TRUTNA, TODD URNESS, TODD B. URNESS, DAVID VOLK, DAVID J. VOLK
DIRECTOR
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
COMMERCIAL BANKING
STATE COMMERCIAL BANKS [6022]
DECLINE TO DISCLOSE
Debt
2025-06-24
D
COMMERCIAL BANKING
STATE COMMERCIAL BANKS [6022]
DECLINE TO DISCLOSE
Debt
2025-06-24
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
2013-04-30
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
2012-12-31
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
2012-12-10
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2012-11-29
D
COMPUTERS
SERVICES-PREPACKAGED SOFTWARE [7372]
$25,000,001 - $100,000,000
Equity
2009-05-13

